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REGULATION OF BLOOD SUGAR IN INTENSIVE CARE PATIENTS 
 
High blood sugar levels are frequent in intensive care patients, resulting in 
higher mortality and morbidity, and longer stay. GlucoSafe, a computer deci-
sion support system, is developed to assist clinicians in regulating blood sugar. 
The system uses a physiological model of sugar metabolism, including insulin 
production and action, and intestinal uptake of nutrients. However, efficacy will 
depend on how accurately it can predict future blood glucose levels (BG) after a 
glycemic control intervention, based on previously measured BG values.  
 
1-10 hour forward predictions were made using GlucoSafe (GS) and a clinically 
tested model (CC) from New Zealand for 11 hyperglycemic patients, 6 from 
New Zealand and 5 from Denmark. As expected, relative RMS prediction error 
increases with prediction interval for both models and cohorts. Fig. 1 shows 
similar predictive power for GS and CC up to 3-5 hours. GS outperforms CC 
for predictions beyond 5 hours. A CC-based protocol has been successfully 
applied for glycemic control in Christchurch. Therefore, GlucoSafe is expected 
to be a safe, effective tool for blood sugar regulation in intensive care. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: RMS glucose prediction error (%) vs. prediction interval.  
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